|
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults |
|
|
|
Titel: |
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults |
Auteur: |
Toledo-Romani, María Eugenia García-Carmenate, Mayra Verdecia-Sánchez, Leslyhana Pérez-Rodríguez, Suzel Rodriguez-González, Meybis Valenzuela-Silva, Carmen Paredes-Moreno, Beatriz Sanchez-Ramirez, Belinda González-Mugica, Raúl Hernández-Garcia, Tays Orosa-Vázquez, Ivette Díaz-Hernández, Marianniz Pérez-Guevara, María Teresa Enriquez-Puertas, Juliet Noa-Romero, Enrique Palenzuela-Diaz, Ariel Baro-Roman, Gerardo Mendoza-Hernández, Ivis Muñoz, Yaima Gómez-Maceo, Yanet Santos-Vega, Bertha Leysi Fernandez-Castillo, Sonsire Climent-Ruiz, Yanet Rodríguez-Noda, Laura Santana-Mederos, Darielys García-Vega, Yanelda Chen, Guang-Wu Doroud, Delaram Biglari, Alireza Boggiano-Ayo, Tammy Valdés-Balbín, Yury Rivera, Daniel G. García-Rivera, Dagmar Vérez-Bencomo, Vicente |
Verschenen in: |
Med |
Paginering: |
Jaargang 3 () nr. 11 pagina's 760-773.e5 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|